ARCHIVES

Top Management Shifts At Bristol-Myers Squibb Oncology, R&D Units

This article is from The Cancer Letter archive.

Vol. 21 No. 38 | October 6, 1995

Download PDF Visit The Full Archive

Related Articles

Revlimid Plus Steroid Effective In Clinical Trial

November 30, 2007

New Creatinine Test Raises Questions About Accuracy Of Carboplatin Dosing

October 8, 2010

Social Networks Influence Decision To Quit Smoking

May 30, 2008

Progress Requires More Etiologists, D’Angio Says

September 15, 1978

New Cancer Control Projects Aimed At Upgrading Care At Community Level; 56 Contracts Anticipated

November 15, 1974

NCI, FDA, Correlogic To Begin Large Trial Of Protein Pattern Diagnostic System for Ovarian Cancer

June 28, 2002